Bedmutha Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 7:43 am

Competitors of Bedmutha Industries Ltd

All Competitor Stocks of Bedmutha Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:00 pm

Below is a detailed analysis of the quarterly data for Bedmutha Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 310.60 Cr.. The value appears strong and on an upward trend. It has increased from 281.72 Cr. (Mar 2025) to 310.60 Cr., marking an increase of 28.88 Cr..
• For Expenses, as of Jun 2025, the value is 300.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 271.62 Cr. (Mar 2025) to 300.09 Cr., marking an increase of 28.47 Cr..
• For Operating Profit, as of Jun 2025, the value is 10.51 Cr.. The value appears strong and on an upward trend. It has increased from 10.10 Cr. (Mar 2025) to 10.51 Cr., marking an increase of 0.41 Cr..
• For OPM %, as of Jun 2025, the value is 3.38%. The value appears to be declining and may need further review. It has decreased from 3.59% (Mar 2025) to 3.38%, marking a decrease of 0.21%.
• For Other Income, as of Jun 2025, the value is 0.78 Cr.. The value appears to be declining and may need further review. It has decreased from 6.16 Cr. (Mar 2025) to 0.78 Cr., marking a decrease of 5.38 Cr..
• For Interest, as of Jun 2025, the value is 8.96 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.16 Cr. (Mar 2025) to 8.96 Cr., marking a decrease of 0.20 Cr..
• For Depreciation, as of Jun 2025, the value is 5.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.01 Cr. (Mar 2025) to 5.67 Cr., marking an increase of 0.66 Cr..
• For Profit before tax, as of Jun 2025, the value is -3.34 Cr.. The value appears to be declining and may need further review. It has decreased from 2.09 Cr. (Mar 2025) to -3.34 Cr., marking a decrease of 5.43 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -3.30 Cr.. The value appears to be declining and may need further review. It has decreased from 2.07 Cr. (Mar 2025) to -3.30 Cr., marking a decrease of 5.37 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.02. The value appears to be declining and may need further review. It has decreased from 0.64 (Mar 2025) to -1.02, marking a decrease of 1.66.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:40 am

Growth

Last Updated: September 5, 2025, 12:40 am

Balance Sheet

Last Updated: June 16, 2025, 12:24 pm

Below is a detailed analysis of the balance sheet data for Bedmutha Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 32.00 Cr..
• For Reserves, as of Mar 2025, the value is 113.00 Cr.. The value appears strong and on an upward trend. It has increased from 88.00 Cr. (Mar 2024) to 113.00 Cr., marking an increase of 25.00 Cr..
• For Borrowings, as of Mar 2025, the value is 217.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 235.00 Cr. (Mar 2024) to 217.00 Cr., marking a decrease of 18.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 292.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 211.00 Cr. (Mar 2024) to 292.00 Cr., marking an increase of 81.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 655.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 566.00 Cr. (Mar 2024) to 655.00 Cr., marking an increase of 89.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 181.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2024) to 181.00 Cr., marking an increase of 23.00 Cr..
• For CWIP, as of Mar 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2024) to 38.00 Cr., marking an increase of 13.00 Cr..
• For Investments, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
• For Other Assets, as of Mar 2025, the value is 432.00 Cr.. The value appears strong and on an upward trend. It has increased from 380.00 Cr. (Mar 2024) to 432.00 Cr., marking an increase of 52.00 Cr..
• For Total Assets, as of Mar 2025, the value is 655.00 Cr.. The value appears strong and on an upward trend. It has increased from 566.00 Cr. (Mar 2024) to 655.00 Cr., marking an increase of 89.00 Cr..

However, the Borrowings (217.00 Cr.) are higher than the Reserves (113.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Bedmutha Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.69. This value is within the healthy range. It has increased from 6.49 (Mar 24) to 7.69, marking an increase of 1.20.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.69. This value is within the healthy range. It has increased from 6.49 (Mar 24) to 7.69, marking an increase of 1.20.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.73. This value is within the healthy range. It has decreased from 14.55 (Mar 24) to 13.73, marking a decrease of 0.82.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.03. It has increased from 37.34 (Mar 24) to 45.03, marking an increase of 7.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.03. It has increased from 37.34 (Mar 24) to 45.03, marking an increase of 7.69.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 325.23. It has increased from 251.68 (Mar 24) to 325.23, marking an increase of 73.55.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 24.86. This value is within the healthy range. It has decreased from 25.54 (Mar 24) to 24.86, marking a decrease of 0.68.
• For PBIT / Share (Rs.), as of Mar 25, the value is 18.81. This value is within the healthy range. It has increased from 17.27 (Mar 24) to 18.81, marking an increase of 1.54.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.69. This value is within the healthy range. It has increased from 6.28 (Mar 24) to 7.69, marking an increase of 1.41.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.69. This value is within the healthy range. It has increased from 6.28 (Mar 24) to 7.69, marking an increase of 1.41.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.69. This value is within the healthy range. It has increased from 6.49 (Mar 24) to 7.69, marking an increase of 1.20.
• For PBDIT Margin (%), as of Mar 25, the value is 7.64. This value is below the healthy minimum of 10. It has decreased from 10.14 (Mar 24) to 7.64, marking a decrease of 2.50.
• For PBIT Margin (%), as of Mar 25, the value is 5.78. This value is below the healthy minimum of 10. It has decreased from 6.86 (Mar 24) to 5.78, marking a decrease of 1.08.
• For PBT Margin (%), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 10. It has decreased from 2.49 (Mar 24) to 2.36, marking a decrease of 0.13.
• For Net Profit Margin (%), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 5. It has decreased from 2.49 (Mar 24) to 2.36, marking a decrease of 0.13.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 8. It has decreased from 2.57 (Mar 24) to 2.36, marking a decrease of 0.21.
• For Return on Networth / Equity (%), as of Mar 25, the value is 17.08. This value is within the healthy range. It has decreased from 17.38 (Mar 24) to 17.08, marking a decrease of 0.30.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.14. This value is within the healthy range. It has decreased from 17.66 (Mar 24) to 16.14, marking a decrease of 1.52.
• For Return On Assets (%), as of Mar 25, the value is 3.79. This value is below the healthy minimum of 5. It has increased from 3.70 (Mar 24) to 3.79, marking an increase of 0.09.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.96. This value is within the healthy range. It has decreased from 1.23 (Mar 24) to 0.96, marking a decrease of 0.27.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.50. This value exceeds the healthy maximum of 1. It has decreased from 1.95 (Mar 24) to 1.50, marking a decrease of 0.45.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.72. It has increased from 1.52 (Mar 24) to 1.72, marking an increase of 0.20.
• For Current Ratio (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.47 (Mar 24) to 1.51, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.22 (Mar 24) to 1.24, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.60. This value exceeds the healthy maximum of 8. It has increased from 9.40 (Mar 24) to 11.60, marking an increase of 2.20.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.23. This value is below the healthy minimum of 3. It has decreased from 2.32 (Mar 24) to 2.23, marking a decrease of 0.09.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.69. This value is below the healthy minimum of 3. It has increased from 1.57 (Mar 24) to 1.69, marking an increase of 0.12.
• For Enterprise Value (Cr.), as of Mar 25, the value is 728.06. It has decreased from 912.69 (Mar 24) to 728.06, marking a decrease of 184.63.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.69, marking a decrease of 0.43.
• For EV / EBITDA (X), as of Mar 25, the value is 9.08. This value is within the healthy range. It has decreased from 11.08 (Mar 24) to 9.08, marking a decrease of 2.00.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.49, marking a decrease of 0.35.
• For Price / BV (X), as of Mar 25, the value is 3.60. This value exceeds the healthy maximum of 3. It has decreased from 5.72 (Mar 24) to 3.60, marking a decrease of 2.12.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.49, marking a decrease of 0.35.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness